By Josh White
Date: Monday 13 Apr 2026
(Sharecast News) - Cambridge Cognition reported a return to growth in new sales orders for 2025 on Monday, alongside an expanding order book and improving financial position, despite a decline in revenue reflecting a weaker opening backlog.
By Josh White
Date: Monday 16 Feb 2026
(Sharecast News) - Cambridge Cognition announced on Monday that it has entered into a commercialisation agreement with India-based brain health platform Ivory to deploy its 'CANTAB Pathway' digital cognitive assessment tool across healthcare and consumer health markets in India.
By Josh White
Date: Monday 19 Jan 2026
(Sharecast News) - Cambridge Cognition reported a sharp rebound in commercial momentum on Monday, with new sales orders rising strongly and the order book expanding in 2025, although full-year revenue fell as expected due to a weaker opening backlog.
| Currency | UK Pounds |
| Share Price | 34.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 43.50p |
| 52 Week Low | 25.00p |
| Volume | 217 |
| Shares Issued | 46.63m |
| Market Cap | £15.85m |
| Beta | 0.00 |
| RiskGrade | 282 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 1 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| No dividends found |
| Time | Volume / Share Price |
| 14:50 | 176 @ 35.00p |
| 09:14 | 41 @ 33.41p |
| CEO | Rob Baker |
| CFO | Ronald Openshaw |
You are here: research